Ureteral Neoplasms: all 121 studies
Page 2 of 2. Open to participants first (19), then studies with results posted, then the rest; newest registration first within each.
- Cisplatin Plus Gemcitabine With or Without Paclitaxel in Treating Patients With Stage IV Urinary Tract CancerCompletedNCT00022191Phase 3
- Ixabepilone in Treating Patients With Advanced Urinary Tract CancerCompletedNCT00021099Phase 2
- Combination Chemotherapy in Treating Patients With Transitional Cell Cancer of the UrotheliumCompletedNCT00014274Phase 2/3
- S0031, ZD 1839 in Treating Patients With Advanced Cancer of the Urinary TractCompletedNCT00014144Phase 2
- Arsenic Trioxide in Treating Patients With Urothelial CancerCompletedNCT00009867Phase 2
- R115777 in Treating Patients With Advanced Bladder CancerCompletedNCT00006376Phase 2
- SCH 66336 Plus Gemcitabine in Treating Patients With Advanced Cancer of the Urinary TractCompletedNCT00006351Phase 2
- Surgery Plus Combination Chemotherapy and Radiation Therapy in Treating Patients With Cancer of the Urinary TractCompletedNCT00006111Phase 2
- Nitrocamptothecin in Treating Patients With Metastatic Cancer of the Urinary TractCompletedNCT00006026Phase 2
- Combination Chemotherapy Plus Filgrastim in Treating Patients With Locally Recurrent or Advanced Urothelium CancerStatus unknownNCT00005958Phase 2
- Trastuzumab and Combination Chemotherapy in Treating Patients With Locally Recurrent or Metastatic Urinary Tract CancerCompletedNCT00005831Phase 2
- Combination Chemotherapy in Treating Patients With Advanced Cancer of the Urothelium and Decreased Kidney FunctionCompletedNCT00005644Phase 2
- Trastuzumab in Treating Patients With Previously Treated, Locally Advanced, or Metastatic Cancer of the UrotheliumTerminatedNCT00004856Phase 2
- Docetaxel and Gemcitabine in Treating Patients With Progressive Regional or Metastatic Bladder CancerCompletedNCT00004223Phase 2
- Oxaliplatin in Treating Patients With Metastatic Bladder CancerCompletedNCT00004203Phase 2
- Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/NeuCompletedNCT00004074Phase 1
- Two-Drug Combination Chemotherapy Compared With Four-Drug Combination Chemotherapy in Treating Patients With Advanced Cancer of the UrotheliumCompletedNCT00003376Phase 3
- Combination Chemotherapy in Treating Patients With Advanced Bladder or Kidney CancerCompletedNCT00003342Phase 1
- Fluorouracil in Treating Patients With Recurrent or Metastatic Bladder CancerCompletedNCT00003175Phase 2
- Combination Chemotherapy in Treating Patients With Metastatic or Locally Advanced Bladder CancerCompletedNCT00003105Phase 1/2
- Piritrexim in Treating Patients With Advanced Cancer of the Urinary TractCompletedNCT00002914Phase 2